A Thai hospital’s new fast-track dialysis protocol cut deaths from a rare metformin complication nearly in half. The study proves that rapid, organized action can make a lifesaving difference.
Metformin-associated lactic acidosis (MALA) is an uncommon but potentially life-threatening complication linked to the diabetes drug metformin. The condition occurs when lactic acid builds up faster than the body can remove it. To improve how MALA is recognized and treated, researchers created and evaluated a standardized protocol for diagnosis and rapid care. The results were presented at ASN Kidney Week 2025.
New Protocol Prioritizes Rapid Dialysis
The treatment plan focused on starting dialysis as soon as possible, using intermittent hemodialysis, continuous kidney replacement therapy, or peritoneal dialysis. This protocol was put into practice at Maharat Nakhonratchasima Hospital (MNRH) in Thailand. Burirum Hospital (BH) acted as a comparison site and did not adopt the new approach.
Over a five-year period, the team reviewed 347 total cases (70 at MNRH before the protocol, 129 after the protocol, and 148 at BH).
Significant Improvements in Survival and Treatment Timing
After the protocol was introduced at MNRH, the 30-day mortality rate dropped sharply from 25.7% to 13.9%. In contrast, Burirum Hospital saw no improvement during the same period (27.2% and 30%). Mortality at MNRH continued to decline throughout the intervention, with rates falling by 2.08% per quarter.
The average time between hospital arrival and the start of dialysis, known as door-to-dialysis time, also decreased from 870 minutes to 690 minutes. Awareness of MALA among medical teams rose from 38.5% to 89.9% following implementation, indicating stronger recognition and faster clinical action.
Fast-Track Care Improves Outcomes
“A standardized MALA protocol covering diagnosis, access, and treatment shortened door-to-dialysis time, increased awareness, and reduced care variation,” said corresponding author Watanyu Parapiboon, MD, of Maharat Nakhon Ratchasima Hospital, in Thailand. “Fast-track dialysis pathways should be adopted for time-sensitive conditions like MALA. Availability of all dialysis modalities ensures flexibility and enables timely treatment initiation.”
Metformin and Metformin-Associated Lactic Acidosis Background
What is Metformin?
Metformin is one of the most widely used medications for treating type 2 diabetes. It helps lower blood glucose by reducing the liver’s glucose production and improving the body’s sensitivity to insulin. It is generally safe, well tolerated, and rarely causes low blood sugar. Metformin is also being studied for potential benefits beyond diabetes, including effects on weight, cardiovascular health, and aging.
How Common is Metformin Use?
Millions of people worldwide take metformin as a first-line treatment for type 2 diabetes. Its long history of use and strong safety profile make it a standard therapy for managing high blood sugar.
What is Metformin-Associated Lactic Acidosis (MALA)?
Metformin-associated lactic acidosis (MALA) is a rare but severe complication in which lactic acid accumulates in the bloodstream. This buildup can lead to dangerously low blood pH and can become life-threatening without rapid treatment.
How Rare Is MALA?
MALA is extremely uncommon. It typically occurs in people who have additional risk factors such as kidney impairment, liver disease, severe infection, dehydration, or conditions that reduce oxygen delivery to tissues.
Symptoms of MALA
Symptoms may include nausea, vomiting, abdominal discomfort, rapid breathing, weakness, confusion, and, in advanced cases, low blood pressure and organ failure.
How Is MALA Treated?
Treatment focuses on stabilizing the patient and rapidly clearing lactic acid from the blood. This often requires urgent dialysis, along with supportive care and management of underlying conditions.
Why Early Detection Matters
Because MALA can progress quickly, fast diagnosis and immediate treatment dramatically improve survival. Hospitals that use standardized protocols and fast-track dialysis pathways see better outcomes and lower mortality rates.
Meeting: ASN Kidney Week
Study: “Reducing Mortality in Metformin-Associated Lactic Acidosis (MALA) Through a Fast-Track Clinical Pathway: A Controlled Interrupted Time SeriesQuality Improvement Study”
Never miss a breakthrough: Join the SciTechDaily newsletter.
Follow us on Google and Google News.